Clinical trial
Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant
NCT00466219 · University Hospital, Geneva, Other · Completed
Key facts
| NCT number | NCT00466219 |
|---|---|
| Title | Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant |
| Lead sponsor | University Hospital, Geneva, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Ribavirin, Pegylated interferon alpha2a |
| Enrollment | 25 |
| Start date | May 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Apr 27, 2007 |
| Last update posted | Apr 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: